Cardiac atrial natriuretic factor during evolution of congestive heart failure
Mark A. Perrella(Brigham and Women's Hospital), John C. Burnett(Mayo Clinic in Arizona), Margaret M. Redfield(Mayo Clinic in Arizona), C Wei(Mayo Clinic), T. R. Schwab(Mayo Clinic), Brian O’Murchu, Brooks S. Edwards(Mayo Clinic)
American Journal of Physiology-Heart and Circulatory Physiology
April 1, 1992
Cited by 37
Related Papers
Valvular Heart Disease Associated with Fenfluramine–Phentermine
|New England Journal of Medicine|1997|1.6k
Exercise Hemodynamics Enhance Diagnosis of Early Heart Failure With Preserved Ejection Fraction
|Circulation Heart Failure|2010|1.1k
Coronary Microvascular Rarefaction and Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction
|Circulation|2015|848
Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis.
|Proceedings of the National Academy of Sciences|1994|806
Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life.
|Circulation Research|1993|776